Company Search:
Advanced Search
Sponsored Links
Replek AD Skopje Company Snapshot
Replek AD Skopje operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Replek AD Skopje with three other pharmaceutical manufacturers in Europe: Pierrel of Italy (2016 sales of 14.27 million Euro [US$17.32 million] ), Science In Sport Plc of the United Kingdom (£12.24 million [US$16.73 million] ), and Diod PAO which is based in Russia (885.68 million Russian Rubles [US$15.63 million] ).

Sales Analysis. Replek AD Skopje reported sales of 829.32 million Denar (US$16.35 million) for the year ending December of 2016. This represents an increase of 2.4% versus 2015, when the company's sales were 809.83 million Denar. Despite this increase, sales are still well below the level achieved in 2014, when Replek AD Skopje reported sales of 1.11 billion Denar.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Replek AD Skopje
  Stock Performance Chart for Replek AD Skopje
  Stock Data: Recent Stock Performance:
  Current Price (1/10/2018): 54,800
(Figures in Denar)
1 Week n/a   13 Weeks 1.3%  
4 Weeks 4.0%   52 Weeks 27.4%  
Replek AD Skopje Key Data:
  Ticker: REPL Country: Macedonia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 829,319,000
(Year Ending Jan 2017).
Employees: 352
  Currency: Denar Market Cap: 1,420,416,000
  Fiscal Yr Ends: December Shares Outstanding: 25,920
  Share Type: Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.